Authors:
GALLAGHER M
ALLEN SL
STEVENSON J
HILLER K
OMARA V
VELAGAPUDI R
MITCHELL E
VILLALONA M
VANECHO D
JAKIMOWICZ K
ALLEN LF
FISCHKOFF S
ODWYER PJ
Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386
Authors:
VILLALONACALERO MA
BAKER SD
HAMMOND L
AYLESWORTH C
ECKHARDT SG
KRAYNAK M
FRAM R
FISCHKOFF S
VELAGAPUDI R
TOPPMEYER D
RAZVILLAS B
JAKIMOWICZ K
VANHOFF DD
ROWINSKY E
Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779
Citation: S. Fischkoff et K. Martin, RESPONSE TO MORE IS NOT ALWAYS BETTER - A CASE FOR LOW-DOSE LEUCOVORIN, Journal of clinical oncology, 11(7), 1993, pp. 1434-1435